Laurant Gauthier

Title: Laurant Gauthier: Innovator in Immunology

Introduction

Laurant Gauthier is a notable inventor based in Marseilles, France. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies that regulate immune responses. His research has implications for therapeutic applications, especially in enhancing natural killer (NK) cell activity.

Latest Patents

Laurant Gauthier holds a patent titled "Nucleic acids encoding human anti-kir antibodies." This patent describes compositions and methods for regulating an immune response in a subject. Specifically, it details human antibodies that modulate the activity of NK cells, thereby potentiating NK cell cytotoxicity in mammalian subjects. The patent also covers fragments and derivatives of these antibodies, as well as pharmaceutical compositions that utilize them for therapeutic purposes.

Career Highlights

Throughout his career, Laurant Gauthier has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Novo Nordisk A/S and Innate Pharma S.A.S. His work in these organizations has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Laurant Gauthier has collaborated with esteemed colleagues in the field, including Alessandro Moretta and Mariella Della Chiesa. These collaborations have further enriched his research and expanded the impact of his work in immunology.

Conclusion

Laurant Gauthier is a distinguished inventor whose work on antibodies has the potential to transform therapeutic approaches in immunology. His contributions continue to influence the field and pave the way for future innovations.